Veraxa Biotech AG - Post de-SPAC (VRXA)

Nasdaq · Pharmaceutical Preparations · Inc. V8

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Veraxa Biotech AG - Post de-SPAC. Most notable: 2026-08-27: Baumann Oliver Rolf (director) bought $75k of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Insider purchase
    Baumann Oliver Rolf (director) bought $75k of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-08-27Baumann Oliver RolfdirectorP50,0001.5$75,000
2026-08-27Antz Christoph RudigerdirectorP5,0001.53$7,650

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings

Veraxa Biotech AG - Post de-SPAC (VRXA): insider trades, federal contracts, lobbying | IP Files